Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TCTR20250218013Phase 3Completed
Phase 3 trial of benzoyl peroxide in acne vulgaris, sponsored by Strategic Wisdom and Research Institute. Primary endpoint: Change in acne skin microbiome. Started Mar 2025; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on TCTR20250218013.